The changes of sub-group of T-lymphocyte in the peripheral blood of the SARS patients

por Wei, Y., Cai, Z., Yang, L., Liu, X., Wang, Y.
Publicado 2006

Effect of short chain fatty acids on the expression of free fatty acid receptor 2 (Ffar2), Ffar3 and early-stage adipogenesis

por Frost, G, Cai, Z, Raven, M, Otway, D T, Mushtaq, R, Johnston, J D
Publicado 2014

Deconvolution of hemodynamic responses along the cortical surface using personalized functional near infrared spectroscopy

por Machado, A, Cai, Z, Vincent, T, Pellegrino, G, Lina, J-M, Kobayashi, E, Grova, C
Publicado 2021

Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells

por Sun, Z-J, Wang, Y, Cai, Z, Chen, P-P, Tong, X-J, Xie, D
Publicado 2008

Comparison of the gut microbiota composition between the wild and captive Tibetan wild ass (Equus kiang)

por Gao, H., Chi, X., Qin, W., Wang, L., Song, P., Cai, Z., Zhang, J., Zhang, T.
Publicado 2019

P1134: OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA POST-CBTK INHIBITOR THERAPY IN THE UNITED STATES AND JAPAN: A STUDY OF TWO REAL-WORLD DATABASES

por Rai, S., Hess, L., Chen, Y., Abada, P., Konig, H., Walgren, R., Tanizawa, Y., Cai, Z., Tajimi, M.
Publicado 2022

Erianin induces G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo

por Wang, H, Zhang, T, Sun, W, Wang, Z, Zuo, D, Zhou, Z, Li, S, Xu, J, Yin, F, Hua, Y, Cai, Z
Publicado 2016

Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3

por Zhang, T, Li, J, Yin, F, Lin, B, Wang, Z, Xu, J, Wang, H, Zuo, D, Wang, G, Hua, Y, Cai, Z
Publicado 2017

Correction: Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3

por Zhang, T., Li, J., Yin, F., Lin, B ., Wang, Z., Xu, J., Wang, H., Zuo, D., Wang, G., Hua, Y., Cai, Z.
Publicado 2019

On the importance of cavity-length and heat dissipation in GaN-based vertical-cavity surface-emitting lasers

por Liu, W. J., Hu, X. L., Ying, L. Y., Chen, S. Q., Zhang, J. Y., Akiyama, H., Cai, Z. P., Zhang, B. P.
Publicado 2015

349 Development of a digital tool for home-based monitoring of skin disease for older adults

por van Egmond, S., Cai, Z., Nava, V., Rapaport, B., Ko, J., Chiou, A., Sarin, K.Y., Tang, J., Bousheri, S., Zhang, L., Linos, E.
Publicado 2022

Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response

por Nickerson, M L, Witte, N, Im, K M, Turan, S, Owens, C, Misner, K, Tsang, S X, Cai, Z, Wu, S, Dean, M, Costello, J C, Theodorescu, D
Publicado 2017

Magnetic coupling at rare earth ferromagnet/transition metal ferromagnet interfaces: A comprehensive study of Gd/Ni

por Higgs, T. D. C., Bonetti, S., Ohldag, H., Banerjee, N., Wang, X. L., Rosenberg, A. J., Cai, Z., Zhao, J. H., Moler, K. A., Robinson, J. W. A.
Publicado 2016

Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma

por Cai, Z., Zhang, J., He, Y., Xia, L., Dong, X., Chen, G., Zhou, Y., Hu, X., Zhong, S., Wang, Y., Chen, H., Xie, D., Liu, X., Liu, J.
Publicado 2021

PB2011: CHIDAMIDE COMBINED WITH THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (TC2D) AS AN ORAL QUADRUPLET REGIMEN FOR RELAPSED/REFRACTORY MYELOMA PATIENTS: INITIAL RESULTS OF A...

por Li, Y., He, J., Han, X., Zheng, G., Zhang, E., Chen, Q., Yang, Y., He, D., Zhao, Y., Fu, J., Shou, L., Jiang, W., Jiang, W., Qian, S., Hu, H., He, H., Cai, Z.
Publicado 2022

Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study

por Lu, A, Fang, Y, Du, X, Li, Y, Cai, Z, Yu, K, Zhao, L, Wang, B, Wu, J, Cheng, Y, Zuo, Y, Jia, Y, Tan, F, Ding, L, Lu, J, Zhang, L, Huang, X
Publicado 2016

P895: DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE (D-VD) VERSUS BORTEZOMIB AND DEXAMETHASONE (VD) ALONE IN CHINESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): UPDA...

por Fu, W., Li, W., Hu, J., An, G., Wang, Y., Fu, C., Chen, L., Jin, J., Cen, X., Ge, Z., Cai, Z., Niu, T., Qi, M., Gai, X., Li, Q., Liu, W., Liu, W., Yang, X., Chen, X., Lu, J.
Publicado 2022

PB1999: ATG-010 PLUS LOW-DOSE DEXAMETHASONE (SD) IN CHINESE RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PATIENTS PREVIOUSLY RECEIVED CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T)

por Fu, W., Xia, Z., Fu, C., Chen, W., Chang, C., Fang, B., An, G., Wei, Y., Cai, Z., Gao, S., Weng, J., Chen, L., Jing, H., Li, F., Liu, Z., Chen, X., Liu, J., Yu, Y., Wang, A., Fei, Y., Qiu, L.
Publicado 2022

P1119: THE ORAL PI3KΔ INHIBITOR LINPERLISIB FOR THE TREATMENT OF RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: A SINGLE-ARM MULTICENTER PHASE 2 CLINICAL TRIAL

por wang, T., sun, X., qiu, L., su, H., cao, J., li, Z., song, Y., zhang, L., yi, S., qiu, L., zhou, J., wu, H., zhang, W., li, J., zhou, K., zhou, H., yang, Y., li, Z., cen, H., cai, Z., zhang, Z., fu, W., jin, J., li, F., wu, W., gu, X., zhu, W., liu, L., li, Z.
Publicado 2022

Toward High Precision XCO(2) Retrievals From TanSat Observations: Retrieval Improvement and Validation Against TCCON Measurements

por Yang, D., Boesch, H., Liu, Y., Somkuti, P., Cai, Z., Chen, X., Di Noia, A., Lin, C., Lu, N., Lyu, D., Parker, R. J., Tian, L., Wang, M., Webb, A., Yao, L., Yin, Z., Zheng, Y., Deutscher, N. M., Griffith, D. W. T., Hase, F., Kivi, R., Morino, I., Notholt, J., Ohyama, H., Pollard, D. F., Shiomi, K., Sussmann, R., Té, Y., Velazco, V. A., Warneke, T., Wunch, D.
Publicado 2020